Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Michael Hoebartner , Philipp Kiefer , Michael Andrew Borger , et al Added: 3 years ago
Mitral valve regurgitation (MR) is frequently induced by degenerative mitral valve (MV) disease and leads to leaflet prolapse. Therefore, valve repair is a well-proven surgical technique with excellent long-term outcomes.1–5 The risk of declining left ventricle (LV) function or LV enlargement and the development of atrial fibrillation or severe pulmonary hypertension due to chronic volume… View more

Intervention

Vascular Disease and Surgery
TAVI for Pure Aortic Regurgitation With Dedicated Devices
Author(s): Pierluigi Costanzo , Paul Bamborough , Mark Peterson , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
Added: 3 years ago Source:  Edwards
FT. LAUDERDALE, FL, January 30, 2012 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, announced today that new data were presented on high-risk surgical patients with severe aortic stenosis treated with transapical transcatheter aortic valve replacement (TAVR) during the continued access period of Cohort A of The PARTNER… View more
Added: 3 years ago
SAN FRANCISCO, CA, November 10, 2011 -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that data were presented on the quality of life impact and cost effectiveness of transcatheter aortic valve replacement (TAVR) in patients at high risk for traditional open-heart surgery. These data were presented at the… View more
Transseptal Mitral Valve Therapy
Author(s): Marvin H Eng , Dee Dee Wang Added: 3 years ago
Approximately 1.8% of the US population has mitral valve disease,1 and an estimated 106,000 surgeries per year are for the treatment of valvular heart disease.2 A total of 210,529 mitral surgeries were performed from 2000 to 2007, averaging approximately 30,000 mitral valve surgeries yearly in the US, accounting for both combined and isolated mitral procedures, with approximately 60% of surgeries… View more

Vascular Disease and Surgery

Intervention
Alternate Access for TAVI: Stay Clear of the Chest
Author(s): Pavel Overtchouk , Thomas Modine Added: 3 years ago
This article aims to provide an updated comparative review, addressing the respective strengths and weaknesses of different alternative transcatheter aortic valve implantation (TAVI) approaches. The transfemoral (TF) access is favoured by international guidelines on TAVI because of its reported superiority to the transthoracic approach.1–3 In spite of the progress in miniaturisation of new… View more

Vascular Disease and Surgery

Intervention
Transcatheter Aortic Valve Replacement for Native Aortic Valve Regurgitation
Author(s): Roberto Spina , Chris Anthony , David WM Muller , et al Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) with either the balloonexpandable Edwards SAPIEN XT valve (Edwards Lifesciences, Irvine, California), or the self-expandable CoreValve prosthesis (Medtronic, Minneapolis, Minnesota) has become the established therapeutic modality for severe aortic valve stenosis in patients who are not deemed suitable for surgical intervention due to excessively high… View more

Vascular Disease and Surgery

Intervention
Differences in Outcomes and Indications between Sapien and CoreValve Transcatheter Aortic Valve Implantation Prostheses
Author(s): Alia Noorani , Vinayak Bapat Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is an established alternative to surgical valve replacement in the management of calcified severe aortic stenosis in those with co-morbidities or adverse features (advanced age, impaired left ventricular function), or in those where open surgery may be associated with unfavourable technical features, such as previous sternotomy with a patent internal… View more

Vascular Disease and Surgery

Intervention
Shockwave and Non-transfemoral Transcatheter Aortic Valve Replacement
Author(s): Eden C Payabyab , Lindsay S Elbaum , Navneet Sharma , et al Added: 2 years ago

Vascular Disease and Surgery
Author(s): Thomas Walther , Johannes Blumenstein Added: 3 years ago
During the past five years, transcatheter (T) aortic valve implantation (AVI) has evolved as one of the most important clinical innovations in cardiovascular disease. The specific merit of TAVI is to allow for minimally invasive treatment of severe symptomatic aortic stenosis (AS) in elderly and high-risk patients. Since 2005 retrograde transfemoral (TF) and antegrade transapical (TA) aortic… View more

Vascular Disease and Surgery

Intervention